Venkatraman Radhakrishnan/stjude.org
Oct 15, 2023, 16:12
Venky (Venkatraman Radhakrishnan): On multivariate analysis NCI high risk, MRD positive and CD 20 positive associated with inferior survival
Venky (Venkatraman Radhakrishnan), Associate Professor in Medical and Pediatric Oncology at the Cancer Institute in Chennai, India.
50% of ALL has CD 20 expression Not associated with cytogenetics or demographics No difference in MRD positive CD 20 up regulated at end of induction in patients who were CD 20 negative at baseline. More relapse in CD 20 positive baseline
On multivariate analysis NCI high risk, MRD positive and CD 20 positive associated with inferior survival.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 27, 2025, 13:26
Feb 27, 2025, 13:24
Feb 27, 2025, 13:21
Feb 27, 2025, 13:13
Feb 27, 2025, 13:10